The products Sodium Hydroxide, Heptane, or Naphtha must be in child resistant packaging, as required by the Poison Prevention Packaging Act (PPPA). The packaging of the products is not child resistant. The sodium hydroxide poses a risk of chemical burns and irritation to the skin and eyes. The heptane and naphtha pose a risk of eye, nose and throat irritation, headache, lightheadedness, dizziness, lack of coordination and loss of consciousness. In addition, the label on the products violates the Federal Hazardous Substance Act (FHSA) by omitting mandatory information on the packaging.
The packaging is not child resistant as required by the Poison Prevention Packaging Act. The pain relieving cream contains lidocaine, posing a risk of poisoning to young children if they put it on their skin or ingest it.